Skip to main content
Log in

Evidence-based medicine: botulinum toxin A in migraine and tension-type headache

  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The therapeutic effect of botulinum toxin in headache was observed coincidentally. The rationale for this new indication initially met with a great deal of scepticism, because the toxin's mechanism of action, cholinergic chemodenervation, does not fit the pathophysiological concept of migraine and other forms of headache. Meanwhile a fair number of studies have been published which indicate efficacy for botulinum toxin and recommend its use for the treatment of tension headache and migraine. According to the evidence-based medicine criteria, grade I evidence has been demonstrated. In addition the use of botulinum toxin for cluster-headache and secondary headache is discussed.

Further large scale studies will be regarded to demonstrate the long-term efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Göbel, H., Heinze, A., Heinze-Kuhn, K. et al. Evidence-based medicine: botulinum toxin A in migraine and tension-type headache. J Neurol 248 (Suppl 1), I34–I38 (2001). https://doi.org/10.1007/PL00007818

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00007818

Navigation